Publication date: Sep 21, 2026
Cardiovascular disease (CVD) is a significant comorbidity influencing COVID-19 outcome. This study assesses its impact on hospitalized COVID-19 patients at Howard University Hospital. A retrospective analysis was performed on a cohort of 1,580 hospitalized predominantly African American (AA) COVID-19 patients that were classified as CVD (n = 428, 27%) and non-CVD (n = 1,152, 73%) and further stratified by race to assess demographic, clinical, and laboratory differences. CVD patients exhibited higher rates of hypertension (86% vs. 49%), diabetes (47% vs. 25%), and acute kidney injury (37% vs. 21%) compared to non-CVD patients (p
| Concepts | Keywords |
|---|---|
| African American | |
| Cardiovascular Disease | |
| COVID-19 | |
| Gastrointestinal disease |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Cardiovascular Disease |
| disease | MESH | COVID-19 |
| disease | MESH | hypertension |
| disease | MESH | acute kidney injury |
| disease | MESH | Long Covid |
| disease | MESH | Gastrointestinal disease |
Original Article
(Visited 2 times, 1 visits today)